Current pharmacotherapy options for labor induction

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 14, 2012, Pages 2005-2014

  Hawkins, J Seth ^a   Wing, Deborah A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Induction; Labor; Oxytocin; Prostaglandin

Indexed keywords

MISOPROSTOL; NITRIC OXIDE DONOR; OXYTOCIN; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE;

CARDIOTOCOGRAPHY; CESAREAN SECTION; CHILL; CLINICAL EFFECTIVENESS; CONTROLLED DRUG RELEASE; DIARRHEA; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; FETUS DISTRESS; FETUS RISK; FEVER; GEL; GESTATIONAL AGE; HUMAN; HYPONATREMIA; LABOR INDUCTION; MATERNAL MORBIDITY; NAUSEA; PHASE 3 CLINICAL TRIAL (TOPIC); POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SUPPOSITORY; SYSTEMATIC REVIEW (TOPIC); UTERINE ATONY; UTERINE CERVIX RIPENING;

CERVICAL RIPENING; DINOPROSTONE; FEMALE; HUMANS; LABOR, INDUCED; MISOPROSTOL; NITRIC OXIDE DONORS; OXYTOCICS; OXYTOCIN; PREGNANCY;

EID: 84866253533     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.722622     Document Type: Review

References (76)

1. Laughon SK, Zhang J, Grewal J, et al. Induction of labor in a contemporary obstetric cohort. Am J Obstet Gynecol 2012;206(6):486; e1-9
2. Yeast JD, Jones A, Poskin M. Induction of labor and the relationship to cesarean delivery: A review of 7001 consecutive inductions. Am J Obstet Gynecol 1999;180(3 Pt 1):628-33 (Pubitemid 29149138)
3. Beebe LA, Rayburn WF, Beaty CM, et al. Indications for labor induction. Differences between university and community hospitals. J Reprod Med 2000;45(6):469-75 (Pubitemid 30432258)
4. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 107: induction of labor. Obstet Gynecol 2009;114:386
5. Crane J and Maternal-Fetal Medicine Committee. Induction of labour at term. SOGC Clinical practice guideline No. 107. 2001. Available from: http://www.sogc.org/guidelines/public/107E-CPG-August2001.pdf [Accessed 24 June 2012]
6. National Institute for Health and Clinical Excellence (NICE). Induction of labour (CG70). 2008. Available from: http://www.nice.org.uk/CG70 [Accessed 24 June 2012]
7. WHO recommendations for induction of labour. Geneva: world Health Organization, 2011. Available from: http://whqlibdoc.who.int/publications/2011/ 9789241501156-eng.pdf [Accessed 26 June 2012]
8. Seyb ST, Berka RJ, Socol ML, Dooley SL. Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstet Gynecol 1999;94:600-7 (Pubitemid 29460948)
9. Rouse DJ, Weiner SJ, Bloom SL, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Failed labor induction: toward an objective diagnosis. Obstet Gynecol 2011;117(2 Pt 1):267-72
10. Simon CE, Grobman WA. When has an induction failed? Obstet Gynecol 2005;105(4):705-9 (Pubitemid 40432185)
11. Rouse DJ, Owen J, Hauth JC. Criteria for failed labor induction: prospective evaluation of a standardized protocol. Obstet Gynecol 2000;96(5 Pt 1):671-7
12. Ramsey PS, Meyer L, Walkes BA, et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol 2005;105(1):85-90 (Pubitemid 40189916)
13. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 1998;91(5 Pt 2):828-30 (Pubitemid 28192095)
14. Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med 2001;345(1):3-8 (Pubitemid 32640179)
15. Buhimschi CS, Buhimschi IA, Patel S, et al. Rupture of the uterine scar during term labour: contractility or biochemistry? BJOG 2005;112(1):38-42 (Pubitemid 40095078)
16. Landon MB, Hauth JC, Leveno KJ, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351(25):2581-9
17. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001;81(2):629-83 (Pubitemid 32267075)
18. Ryden G, Sjoholm I. The metabolism of oxytocin in pregnant and non-pregnant women. Acta Obstet Gynecol Scand Suppl 1971;9(Suppl 9):37
19. Seitchik J, Amico J, Robinson AG, Castillo M. Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics. Am J Obstet Gynecol 1984;150(3):225-8 (Pubitemid 14000342)
20. Clark S, Belfort M, Saade G, et al. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes. Am J Obstet Gynecol 2007;197(5):480.e1-5
21. Freeman RK, Nageotte M. A protocol for use of oxytocin. Am J Obstet Gynecol 2007;197(5):445-6 (Pubitemid 350011173)
22. Hayes EJ, Weinstein L. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin. Am J Obstet Gynecol 2008;198(6):622.e1-7
23. Patka JH, Lodolce AE, Johnston AK. High-versus low-dose oxytocin for augmentation or induction of labor. Ann Pharmacother 2005;39(1):95-101 (Pubitemid 40052384)
24. Merrill DC, Zlatnik FJ. Randomized, double-masked comparison of oxytocin dosage in induction and augmentation of labor. Obstet Gynecol 1999;94(3):455-63 (Pubitemid 29393087)
25. Satin AJ, Leveno KJ, Sherman ML, et al. High-versus low-dose oxytocin for labor stimulation. Obstet Gynecol 1992;80(1):111-16
26. Lauersen NH, Birnbaum SJ. Water intoxication associated with oxytocin administration during saline-induced abortion. Am J Obstet Gynecol 1975;121(1):2-6
27. Morgan DB, Kirwan NA, Hancock KW, et al. Water intoxication and oxytocin infusion. Br J Obstet Gynaecol 1977;84(1):6-12 (Pubitemid 8114965)
28. Moen V, Brudin L, Rundgren M, Irestedt L. Hyponatremia complicating labour-rare or unrecognised? A prospective observational study. BJOG 2009;116(4):552-61
29. Ophir E, Solt I, Odeh M, Bornstein J. Water intoxication-a dangerous condition in labor and delivery rooms. Obstet Gynecol Surv 2007;62(11):731-8 (Pubitemid 351325951)
30. Sheiner E, Sarid L, Levy A, et al. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: A population-based study. J Matern Fetal Neonatal Med 2005;18(3):149-54 (Pubitemid 41659512)
31. Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol 2011;24(3):255-61
32. Oyelese Y, Ananth CV. Postpartum hemorrhage: Epidemiology, risk factors, and causes. Clin Obstet Gynecol 2010;53(1):147-56
33. Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev 2009(4):CD003246
34. Jozwiak M, Bloemenkamp KW, Kelly AJ, et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev 2012;3:CD001233
35. Samuelsson B, Goldyne M, Granstrom E, et al. Prostaglandins and thromboxanes. Annu Rev Biochem 1978;47:997-1029; Review. No abstract available
36. Rayburn WF. Preinduction cervical ripening: basis and methods of current practice. Obstet Gynecol Surv 2002;57(10):683-92
37. Morrison SF, Nakamura K. Central neural pathways for thermoregulation. Front Biosci 2011;16:74-104
38. Dey I, Lejeune M, Chadee K. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. J Pharmacol 2006;149(6):611-23 (Pubitemid 44748054)
39. Pfizer. Prepidil Package Insert. LAB-0062-5.0. Revised February 2009
40. Forest Laboratories. Cervidil Package Insert. RMC 226. Revised April 2010
41. Shepherd JH, Bennett MJ, Laurence D, et al. Prostaglandin vaginal suppositories: A simple and safe approach to the induction of labor. Obstet Gynecol 1981;58(5):596-600
42. Red Book. Thomson-Reuters. 2010 Edition
43. Blanchard K, Clark S, Winikoff B, et al. Misoprostol for women's health: A review. Obstet Gynecol 2002;99(2):316-32 (Pubitemid 34114006)
44. Towers CV, Briggs GG, Rojas JA. The use of prostaglandin E2 in pregnant patients with asthma. Am J Obstet Gynecol 2004;190(6):1777-80; discussion 1780 (Pubitemid 39006217)
45. Ramsey PS, Ogburn PL Jr, Harris DY, et al. Effect of vaginal pH on efficacy of the dinoprostone gel for cervical ripening/labor induction. Am J Obstet Gynecol 2002;187(4):843-6 (Pubitemid 35178367)
46. Ramsey PS, Ogburn PL Jr, Harris DY, et al. Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labor induction. Am J Obstet Gynecol 2000;182(6):1616-19 (Pubitemid 30437437)
47. Rayburn WF. Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysis. Am J Obstet Gynecol 1989;160(3):529-34 (Pubitemid 19092124)
48. Boulvain M, Kelly A, Irion O. Intracervical prostaglandins for induction of labour. Cochrane Database Syst Rev 2008(1):CD006971
49. Kelly AJ, Malik S, Smith L, et al. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2009(4):CD003101
50. Sciscione AC, McCullough H, Manley JS, et al. A prospective, randomized comparison of Foley catheter insertion versus intracervical prostaglandin E2 gel for preinduction cervical ripening. Am J Obstet Gynecol 1999;180(1 Pt 1):55-60
51. Dalui R, Suri V, Ray P, Gupta I. Comparison of extraamniotic foley catheter and intracervical prostaglandin E gel for preinduction cervical ripening. Acta Obstet Gynecol Scand 2005;84(4):362-7 (Pubitemid 40478185)
52. Pennell CE, Henderson JJ, O'Neill MJ, et al. Induction of labour in nulliparous women with an unfavourable cervix: A randomised controlled trial comparing double and single balloon catheters and PGE2 gel. BJOG 2009;116(11):1443-52
53. Jozwiak M, Oude Rengerink K, Benthem M, PROBAAT Study Group. Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial. Lancet 2011;378(9809):2095-103
54. Goldman JB, Wigton TR. A randomized comparison of extra-amniotic saline infusion and intracervical dinoprostone gel for cervical ripening. Obstet Gynecol 1999;93(2):271-4 (Pubitemid 29068105)
55. Guinn DA, Goepfert AR, Christine M, et al. Extra-amniotic saline, laminaria, or prostaglandin E(2) gel for labor induction with unfavorable cervix: A randomized controlled trial. Obstet Gynecol 2000;96(1):106-12 (Pubitemid 30336290)
56. Sherman DJ, Frenkel E, Pansky M, et al. Balloon cervical ripening with extra-amniotic infusion of saline or prostaglandin E2: A double-blind, randomized controlled study. Obstet Gynecol 2001;97(3):375-80 (Pubitemid 32184696)
57. Cromi A, Ghezzi F, Uccella S, et al. A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter. Am J Obstet Gynecol 2012; Epub ahead of print
58. Sanchez-Ramos L, Kaunitz AM, Delke I, Gaudier FL. Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: A meta-analysis. Obstet Gynecol 1999;94(5 Pt 2):878-83 (Pubitemid 29490929)
59. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010(10):CD000941
60. Fox NS, Saltzman DH, Roman AS, et al. Intravaginal misoprostol versus Foley catheter for labour induction: A meta-analysis. BJOG 2011;118(6):647-54
61. Lin MG, Nuthalapaty FS, Carver AR, et al. Misoprostol for labor induction in women with term premature rupture of membranes: A meta-analysis. Obstet Gynecol 2005;106(3):593-601 (Pubitemid 41208795)
62. Wing DA, Jones MM, Rahall A, et al. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1995a;172(6):1804-10.
63. Wing DA, Rahall A, Jones MM, et al. Misoprostol: An effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995b;172(6):1811-16
64. Kundodyiwa TW, Alfirevic Z, Weeks AD. Low-dose oral misoprostol for induction of labor: A systematic review. Obstet Gynecol 2009;113(2 Pt 1):374-83
65. Thiex NW, Chames MC, Loch-Caruso RK. Tissue-specific induction of COX-2 and prostaglandins in lipopolysaccharide-stimulated extraplacental human gestational membranes in a 2-chamber transwell culture system. Reprod Sci 2010;17(12):1120-9
66. Crane JM, Butler B, Young DC, Hannah ME. Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: A systematic review. BJOG 2006;113(12):1366-76 (Pubitemid 44736680)
67. Frohn WE, Simmons S, Carlan SJ. Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstet Gynecol 2002;99(2):206-10 (Pubitemid 34113990)
68. Muzonzini G, Hofmeyr GJ. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2004(4):CD004221
69. Souza AS, Amorim MM, Feitosa FE. Comparison of sublingual versus vaginal misoprostol for the induction of labour: A systematic review. BJOG 2008;115(11):1340-9
70. Clinicaltrials.gov. Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert for Reducing Time to Vaginal Delivery (EXPEDITE). Available from: http://clinicaltrials.gov/ct2/show/ NCT01127581 [Accessed 26 June 2012]
71. Wing DA, Powers BL, Rayburn WF. Determining dose and endpoints of a controlled-release misoprostol vaginal insert for a phase III trial. J Reprod Med 2008a;53(9):695-6
72. Wing DA. Misoprostol Vaginal Insert Consortium. Misoprostol vaginal insert compared with dinoprostone vaginal insert: A randomized controlled trial. Obstet Gynecol 2008b;112(4):801-12
73. Pevzner L, Alfirevic Z, Powers BL, Wing DA. Cardiotocographic abnormalities associated with misoprostol and dinoprostone cervical ripening and labor induction. Eur J Obstet Gynecol Reprod Biol 2011;156(2):144-8
74. Pevzner L, Rayburn WF, Rumney P, Wing DA. Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol 2009;114(2 Pt 1):261-7
75. Brennan MC, Pevzner L, Wing DA, et al. Retention of dinoprostone vaginal insert beyond 12 hours for induction of labor. Am J Perinatol 2011;28(6):479-84
76. Kelly AJ, Munson C, Minden L. Nitric oxide donors for cervical ripening and induction of labour. Cochrane Database Syst Rev 2011(6):CD006901